Taichenguang: plan to buy back shares with RMB 50 million to RMB 100 million
Taichenguang announced that it plans to buy back shares at a price range of RMB 50 million to RMB 100 million, with a price range of no more than RMB 18.50 per share. The shares to be bought back will be used for subsequent equity incentive or employee stock ownership plan.
This text is a result of machine translation.
Briefing Jan 11, 2021 07:49 PM
· Healthcare
Hot landscape: net profit will increase by about 216% in 2020
In depth
Briefing Jan 11, 2021 10:49 AM
· Healthcare
With a daily detection flux of 1 million, Huada Zhizao automatic nucleic acid extraction and purification instrument helps Hebei epidemic prevention and control
Jan 01, 2021 12:00 AM
Dec 14, 2020 08:20 PM
Research
Consumer Staples, Technology, HealthcareWIA2020 | Rising Tech Stars 2020: Global & China's 100
Dec 09, 2020 09:57 AM
Dec 09, 2020 09:53 AM
Briefing Jan 11, 2021 10:09 AM
· Healthcare
Xinqing medical, a domestic artificial heart and lung device enterprise, won the B round financing of over 100 million yuan from Aurora Borealis venture capital
Briefing Jan 08, 2021 11:30 AM
· Healthcare
Xinyi biological completed 150 million round B financing, and Lilly Asia Fund led investment in Huachuang capital, hillhood venture capital and other follow-up investment
Briefing Jan 08, 2021 09:36 AM
· Healthcare
Focus on high-throughput single-cell omics platform products, search for a reason to complete more than 100 million yuan round a financing
Briefing Jan 07, 2021 04:13 PM
· Healthcare
Qiuzhen medical and tianguangshi have reached strategic cooperation to develop diagnostic kits and tumor drugs
In depth
Briefing Dec 31, 2020 10:20 AM
· Healthcare
Sinopharm new coronavirus vaccine approved
Briefing Dec 30, 2020 05:28 PM
· Healthcare
Another protein component special medical food was approved, and the total number of approved products increased to 57
Briefing Dec 28, 2020 03:13 PM
· Healthcare
Phase I project of Guangzhou Pharmaceutical production base of nuocheng Jianhua was completed
Briefing Dec 28, 2020 02:44 PM
· Healthcare
BGI and Hanwei intelligent medical jointly launched mobile "two cancer" intelligent screening
Briefing Dec 27, 2020 09:30 PM
· Financials
The combined margin simulation system of Dalian Institute of Commerce was put into operation
Briefing Dec 27, 2020 11:05 AM
· Financials
Monarch strategy: the adjustment of the market is limited, optimistic about the restless structure of the spring market
Briefing Dec 26, 2020 07:11 PM
· Healthcare
Shunyi completed three rounds of full coverage nucleic acid testing for farmers' markets and cold chain logistics, all of which were negative.
See more
Read next
Consumer Staples · Analysis
Pinduoduo Poised to Win Next Battle in China's E-commerce War
Jan 22, 2021 10:22 AM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.